To investigate the possible molecular mechanisms underlying the reduced STAT5 activation observed upon Rab6a deletion, we took advantage of T47-D, a human breast cancer-derived cell line commonly used for studying PRL-induced signaling events (Johnson et al., 2010; Baker et al., 2016; Oakes et al., 2017). Here, RAB6A is linked to breast carcinoma.